このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Haemonetics マネジメント
マネジメント 基準チェック /34
Haemonetics'の CEO はChris Simonで、 May2016年に任命され、 の在任期間は 8.08年です。 の年間総報酬は$ 10.69Mで、 9.5%給与と90.5%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.62%を直接所有しており、その価値は$ 27.06M 。経営陣と取締役会の平均在任期間はそれぞれ3.5年と6.5年です。
主要情報
Chris Simon
最高経営責任者
US$11.5m
報酬総額
| CEO給与比率 | 9.4% |
| CEO在任期間 | 8.3yrs |
| CEOの所有権 | 0.5% |
| 経営陣の平均在職期間 | 3.8yrs |
| 取締役会の平均在任期間 | 6.8yrs |
経営陣の近況
Recent updates
These 4 Measures Indicate That Haemonetics (NYSE:HAE) Is Using Debt Reasonably Well
Sep 09
What You Can Learn From Haemonetics Corporation's (NYSE:HAE) P/E
Aug 14Are Investors Undervaluing Haemonetics Corporation (NYSE:HAE) By 46%?
Jul 18Haemonetics Undervalued As It Passes Into A Period Of Softer Reported Growth
Jun 21Does Haemonetics (NYSE:HAE) Deserve A Spot On Your Watchlist?
Apr 30Haemonetics Corporation's (NYSE:HAE) Share Price Matching Investor Opinion
Apr 12Haemonetics Corporation (NYSE:HAE) Shares Could Be 35% Below Their Intrinsic Value Estimate
Mar 07Haemonetics Corporation: Improved Performance, Another Bolt-On Deal
Mar 06The Strong Earnings Posted By Haemonetics (NYSE:HAE) Are A Good Indication Of The Strength Of The Business
Feb 15The Price Is Right For Haemonetics Corporation (NYSE:HAE)
Jan 01Haemonetics: Solid Performance Of This Blood Play
Nov 22Here's Why We Think Haemonetics (NYSE:HAE) Might Deserve Your Attention Today
Nov 14Is Haemonetics (NYSE:HAE) A Risky Investment?
Oct 24Haemonetics Offers Relatively Rare Momentum In A Tough Medical Device Environment
Oct 13Haemonetics' Fiscal Q1 2024: Blood, Sweat, And Stellar Gains
Aug 09Here's Why Haemonetics (NYSE:HAE) Has Caught The Eye Of Investors
Aug 09An Intrinsic Calculation For Haemonetics Corporation (NYSE:HAE) Suggests It's 48% Undervalued
Jul 25Haemonetics (NYSE:HAE) Has A Rock Solid Balance Sheet
Jul 07Haemonetics (NYSE:HAE) Has A Rock Solid Balance Sheet
Apr 06Is There An Opportunity With Haemonetics Corporation's (NYSE:HAE) 46% Undervaluation?
Mar 19Haemonetics Executing Well, But Valuation Dogged By Concerns About A Large Customer
Feb 16Haemonetics: Earnings Rate Of Change Justifies High Multiples
Feb 01We Think Haemonetics (NYSE:HAE) Can Manage Its Debt With Ease
Jan 05Is There An Opportunity With Haemonetics Corporation's (NYSE:HAE) 36% Undervaluation?
Dec 15Haemonetics Q2 2023 Earnings Preview
Nov 04Haemonetics (NYSE:HAE) Seems To Use Debt Rather Sparingly
Oct 04Haemonetics: Plasma Thesis Continues To Play Out, Reiterate Buy
Sep 06Haemonetics reaches new 52-week high; shares up 41% YTD
Aug 24Haemonetics reports Q2 earnings beat; raises FY22 guidance
Aug 10A Look At The Intrinsic Value Of Haemonetics Corporation (NYSE:HAE)
Aug 10Here's Why Haemonetics (NYSE:HAE) Can Manage Its Debt Responsibly
Jul 03Haemonetics: Upside Case Hinges On Blood Plasma Collection Market
Jun 11CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 29 2024 | n/a | n/a | US$115m |
| Mar 30 2024 | US$12m | US$1m | US$118m |
| Dec 30 2023 | n/a | n/a | US$127m |
| Sep 30 2023 | n/a | n/a | US$128m |
| Jul 01 2023 | n/a | n/a | US$137m |
| Apr 01 2023 | US$11m | US$1m | US$115m |
| Dec 31 2022 | n/a | n/a | US$96m |
| Oct 01 2022 | n/a | n/a | US$86m |
| Jul 02 2022 | n/a | n/a | US$68m |
| Apr 02 2022 | US$9m | US$945k | US$43m |
| Jan 01 2022 | n/a | n/a | US$23m |
| Oct 02 2021 | n/a | n/a | US$31m |
| Jul 03 2021 | n/a | n/a | US$64m |
| Apr 03 2021 | US$9m | US$963k | US$79m |
| Dec 26 2020 | n/a | n/a | US$108m |
| Sep 26 2020 | n/a | n/a | US$106m |
| Jun 27 2020 | n/a | n/a | US$96m |
| Mar 28 2020 | US$9m | US$937k | US$77m |
| Dec 28 2019 | n/a | n/a | US$80m |
| Sep 28 2019 | n/a | n/a | US$68m |
| Jun 29 2019 | n/a | n/a | US$49m |
| Mar 30 2019 | US$9m | US$894k | US$55m |
| Dec 29 2018 | n/a | n/a | US$46m |
| Sep 29 2018 | n/a | n/a | US$21m |
| Jun 30 2018 | n/a | n/a | US$23m |
| Mar 31 2018 | US$8m | US$858k | US$46m |
報酬と市場: Chrisの 総報酬 ($USD 10.69M ) は、 US市場 ($USD 6.83M ) の同規模の企業の平均を上回っています。
報酬と収益: Chrisの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Chris Simon (60 yo)
8.3yrs
在職期間
US$11,545,113
報酬
Mr. Christopher A. Simon, also known as Chris, has been the Chief Executive Officer and President of Haemonetics Corporation since May 16, 2016 and has been its Director since May 2016. He joined Haemoneti...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO, President & Director | 8.3yrs | US$11.55m | 0.54% $ 21.2m | |
| CFO, Executive VP & Financial Officer | 2.4yrs | US$3.15m | 0.0093% $ 364.7k | |
| Executive VP & CTO | 4.4yrs | US$2.54m | 0.025% $ 967.7k | |
| Executive VP | 7.5yrs | US$3.07m | 0.038% $ 1.5m | |
| Executive Vice President of Global Manufacturing & Supply Chain | 6.1yrs | US$2.43m | 0.038% $ 1.5m | |
| VP, Chief Accounting Officer & Principal Accounting Officer | 1.9yrs | データなし | 0.00027% $ 10.6k | |
| Senior Director of Investor Relations | 4.9yrs | データなし | データなし | |
| Senior Vice President of Strategy & Corporate Development | 1.4yrs | データなし | データなし | |
| Senior VP & Chief Human Resources Officer | 3.1yrs | データなし | 0.023% $ 899.5k | |
| Senior VP & Chief Medical Officer | 1.4yrs | データなし | データなし | |
| President of Global Hospital | 5yrs | US$2.48m | 0.036% $ 1.4m | |
| Senior Vice President of Global Quality Assurance | 3.2yrs | データなし | データなし |
3.8yrs
平均在職期間
55yo
平均年齢
経験豊富な経営陣: HAEの経営陣は 経験豊富 であると考えられます ( 3.5年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| CEO, President & Director | 8yrs | US$11.55m | 0.54% $ 21.2m | |
| Independent Director | 6.9yrs | US$295.73k | 0.035% $ 1.4m | |
| Independent Director | 4.4yrs | US$283.73k | 0.016% $ 633.1k | |
| Independent Chairman | 6.7yrs | US$449.98k | 0.024% $ 937.5k | |
| Independent Director | 5.4yrs | US$269.95k | 0.019% $ 745.9k | |
| Independent Director | 18.7yrs | US$280.73k | 0.032% $ 1.2m | |
| Independent Director | 10.2yrs | US$292.95k | 0.035% $ 1.4m | |
| Independent Director | 3.1yrs | US$272.95k | 0.011% $ 444.7k | |
| Member of Scientific Advisory Council | no data | データなし | データなし | |
| Member of Scientific Advisory Council | no data | データなし | データなし | |
| Member of Scientific Advisory Council | no data | データなし | データなし | |
| Member of Scientific Advisory Council | no data | データなし | データなし |
6.8yrs
平均在職期間
70yo
平均年齢
経験豊富なボード: HAEの 取締役会 は 経験豊富 であると考えられます ( 6.5年の平均在任期間)。